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Summary 16 
Porcine circovirus 3 (PCV-3) has been identified in pigs affected by different disease 17 
conditions, although its pathogenicity remains unclear. The objective of the present 18 
study was to assess the frequency of PCV-3 infection in serum samples from animals 19 
suffering from postweaning respiratory or digestive disorders as well as in healthy 20 
animals. A total of 315 swine serum samples were analysed for PCV-3 DNA detection 21 
by conventional PCR; positive samples were further assayed with a quantitative PCR 22 
and partially sequenced. Sera were obtained from 4 week- to 4 month-old pigs clinically 23 
diagnosed with respiratory (n=129) or digestive (n=126) disorders. Serum samples of 24 
age-matched healthy animals (n=60) served as negative control. Pigs with clinical 25 
respiratory signs had a wide variety of pulmonary lesions including suppurative 26 
bronchopneumonia, interstitial pneumonia, fibrinous-necrotizing pneumonia and/or 27 
pleuritis. Animals with enteric signs displayed histopathological findings like villus 28 
atrophy and fusion, catarrhal enteritis and/or catarrhal colitis. Overall, PCV-3 DNA was 29 
detected in 19 out of 315 analysed samples (6.0%). Among the diseased animals, PCV-30 
3 was found in 6.2% (8 out of 129) and 5.6% (7 out of 126) of pigs with respiratory and 31 
digestive disorders, respectively. The frequency of PCV-3 PCR positive samples among 32 
healthy pigs was 6.7% (4 out of 60). No apparent association was observed between 33 
PCR positive cases and any type of histopathological lesion. The phylogenetic analysis 34 
of the partial genome sequences obtained showed high identity among viruses from the 35 
three groups of animals studied. In conclusion, PCV-3 was present in the serum of 36 
diseased and healthy pigs to similar percentages, suggesting that this virus does not 37 
seem to be causally associated with respiratory or enteric disorders.  38 
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1. INTRODUCTION  43 
Circoviruses are circular, non-enveloped, single-stranded DNA viruses belonging 44 
to family Circoviridae, genus Circovirus (Rosario et al., 2017). Three types of porcine 45 
circoviruses (PCVs) have been described so far, PCV-1, PCV-2 and PCV-3. PCV-1 is 46 
considered non-pathogenic for swine, PCV-2 is an important pathogen for swine 47 
production worldwide causing porcine circovirus diseases (PCVDs) and, finally, the 48 
recently described PCV-3 has not yet been characterized from a pathogenic point of view 49 
(Klaumann, Correa-Fiz et al., 2018).  50 
PCV-3 was discovered in 2015 by next generation sequencing (NGS) methods in 51 
animals with various disease conditions, including digestive disorders, cardiac and 52 
multisystemic inflammation, and respiratory and neurological signs (Phan et al., 2016). 53 
At the same time, PCV-3 was detected in sows displaying reproductive problems, 54 
increased mortality rate, and suffering from respiratory disorders and porcine dermatitis 55 
and nephropathy syndrome (PDNS) ( Palinski et al., 2017). Since the very first description 56 
of PCV-3, this virus has been found in pigs with respiratory clinical signs and lung lesions 57 
(Zhai et al., 2017; Kedkovid et al., 2018; Shen et al., 2018; Qi et al., 2019), digestive 58 
disorders (Zhai et al., 2017; Qi et al., 2019), congenital tremors (Chen et al., 2017), rectal 59 
prolapse (Phan et al., 2016) and periweaning failure-to-thrive syndrome (Franzo et al., 60 
2019). However, several of these studies where PCV-3 was found in diseased animals 61 
failed to provide with healthy age-matched pigs as control groups (Kedkovid et al., 2018, 62 
Palinski et al., 2017, Phan et al., 2016, Shen et al., 2018).  63 
The apparent most consistent relationship of this novel virus with disease 64 
occurrence is regarding respiratory and digestive disorders. Two studies found PCV-3 65 
DNA in pigs with severe and/or mild respiratory disease compared to healthy animals, 66 
pointing out to a potential involvement of this virus in disease causation (Zhai et al., 2017; 67 
Qi et al., 2019). Same studies also suggested a putative association with digestive 68 
disorders based on the higher frequency of detection of the virus DNA in diseased animals 69 
compared to healthy ones (Zhai et al., 2017; Qi et al., 2019).  70 
Taking into account the information of the above described reports, the present 71 
study was aimed to evaluate the putative association of PCV-3 infection in well-72 
pathologically characterized cases of pigs suffering from respiratory or digestive 73 
disorders in comparison to age-matched clinically healthy animals.  74 
 75 
2. MATERIAL AND METHODS 76 
2.1 Samples  77 
The study was performed with 255 swine serum samples obtained from animals 78 
affected by digestive or respiratory disorders necropsied for diagnostic purposes. These 79 
samples were stored at -20ºC at the serum bank of the Veterinary Pathology Diagnostic 80 
Service at the Veterinary School of Barcelona. The selection criteria of these animals 81 
were: 1) age (animals from 1-4 months of age (nursery and grower pigs), and 2) presence 82 
of histopathological lesions at the respiratory (n=129) or enteric (n=126) tracts. A 83 
negative control group of clinically healthy animals were selected for comparison 84 
purposes. A total of 60 sera were retrieved from the serum bank of the Centre de Recerca 85 
en Sanitat Animal (CReSA-IRTA), and consisted in a selection of necropsied  (n=30) and 86 
alive (n=30) 1-4 month-old pigs with no clinical signs and no lesions. The necropsied 87 
animals belonged to control groups of different CReSA experimental inoculation studies. 88 
The clinically healthy live pigs came from previous CReSA field trials. All selected 89 
samples (n=315) were analysed for the presence of PCV-3 DNA. 90 
Pigs affected by respiratory clinical signs (group R) were classified regarding 91 
specific gross and/or microscopic findings (Table 1). Animals with interstitial pneumonia 92 
(IP, n=30), suppurative bronchopneumonia (SBP, n=30), IP plus SBP (IP+SBP, n=30), 93 
pleuritis (P, n=19) and fibrinous-necrotizing pneumonia (FNP, n=20) were selected. 94 
Animals with digestive disorders (group D) were also classified by histopathological 95 
findings, including pigs with catarrhal enteritis (CE, n=55), CE with villi atrophy and 96 
fusion (CE+AFV, n=25) and catarrhal colitis (CC, n=46). The control group was 97 
composed of sera from 60 clinically healthy animals (group H). 98 
 99 
2.2 DNA extraction, and conventional and quantitative PCR methods 100 
DNA was extracted from 200 μL of serum using MagMAx™ Pathogen 101 
RNA/DNA Kit (Applied Biosystems®) according to the manufacturer's protocol.  102 
A conventional PCR targeting the rep gene region (ORF1) of PCV-3 was 103 
designed. Each reaction included 2.5 µL of extracted DNA, 12.5 µL of Go Taq® G2 104 
Green Master Mix (Promega), 0.4 µM of each primer (forward (P1F) 5`-105 
TTGTGGTGCTACGAGTGTCC-3` and reverse (P1R) 5`-106 
CGTCTCCGTCAGAATCCGAG-3`), and sterile water at a final volume of 25 µL. 107 
Amplification was performed using the following thermal conditions: 5 min at 94˚C, 108 
followed by 40 cycles of 1 min at 94˚C, 1 min at 60˚C and 1 min at 72˚C, and a final 109 
elongation of 7 min at 72˚C. A full-length PCV-3 genome in a commercial plasmid 110 
(Klaumann, Dias-Alves et al., 2018) was used as positive control and sterile water as 111 
negative control. The PCR products (418 bp) were checked by electrophoresis on 1.5% 112 
TAE agarose gel.  113 
A real time quantitative PCR (qPCR) to quantify the amount of viral DNA of 114 
conventional PCR positive samples was performed as previously described (Franzo, 115 
Legnardi, Centelleghe et al., 2018), with slight modifications. Briefly, 2 µL of extracted 116 
DNA was added to a mix of 1xDyNAmo Colour flash Probe qPCR mastermix (Thermo 117 
Fisher Scientific), 0.6 µM and 0.3 µM of primers and probe targeting PCV-3 virus, 0.6 118 
µM and 0.3 µM of primers and probe for internal control (IC), and 1 pg of IC plasmid 119 
(Klaumann, Dias-Alves et al., 2018). The qPCR was performed with Applied 120 
Biosystems® 7500 Real-Time machine with cycling parameters of 95˚C for 7 min, 121 
followed by 40 cycles of 95˚C for 10s and 60˚C for 30s. Sterile water was used as negative 122 
controls. A tenfold log dilution of the commercial plasmid mentioned above was used to 123 
construct the standard curve.  The qPCR results were expressed in copies of PCV-3 124 
DNA/µL of serum. 125 
 126 
2.3 PCV-3 sequencing and phylogenetic studies 127 
Two different sequencing strategies based on rep gene and complete genome were 128 
attempted.  129 
Firstly, to partially sequence the rep gene (362 nt), the conventional PCR primers 130 
were used; conditions for amplification included the utilisation of the DNA polymerase 131 
Platinum™ SuperFi™ (Invitrogen™) kit and the thermal protocol of 2 min at 95˚C, 132 
followed by 40 cycles of 30 s at 95˚C, 1 min at 60˚C and 1 min at 72˚C, and a final 133 
elongation of 7 min at 72˚C. The amplicons were purified with a Kit NucleoSpin® Gel 134 
extraction (Macherey-Nagel) according to the manufacturer's protocol and sequenced by 135 
the Sanger method (ABI 3730XL - Macrogen Europe, Madrid, Spain). The quality of the 136 
sequences was analysed by the Finch TV program and trimmed in BioEdit software 7.2.6 137 
(Hall, 1999) together with all the sequences containing the same fragment available in 138 
GenBank (247 sequences, accession date April 03rd, 2019). Clustal Omega (Sievers and 139 
Higgins, 2014) was used to align and generate the percentage of nucleotide identity matrix 140 
with the obtained sequences. Sequences were deposited at the NCBI GenBank with the 141 
accession numbers MK904813 to MK904827. 142 
Secondly, with the aim to sequence the full genome from PCV-3 PCR positive 143 
samples, a rolling circle amplification (RCA) method was attempted to increase the 144 
amount of PCR template using the ThempliPhi 100 amplification Kit (GE Healthcare) as 145 
described by Fux et al. (2018).  For the PCR, 3 µL of the 1:10 diluted RCA product was 146 
used to amplify the complete PCV-3 genome using previously described primers (Fux et 147 
al., 2018) and thermal conditions (Klaumann, Dias-Alves et al., 2018). The amplicons 148 
were purified as described above and subjected to Sanger sequencing (ABI 3730XL - 149 
Macrogen Europe, Madrid, Spain). The raw chromatograms were manually inspected 150 
with Finch TV and the trimming was done with the BioEdit software 7.2.6 (Hall, 1999). 151 
Partial PCV-3 genome sequence assembly was done with the different amplicons using 152 
reference mapped-based strategy (Li and Durbin, 2010). The Integrative Genomics 153 
Viewer (IGV) software (Robinson et al., 2017) was used for visualizing the assembly and 154 
obtaining the consensus sequences for ORF1 and ORF2. Concatenated rep and cap genes 155 
obtained were 1237 nt in length and were subsequently aligned with the 43 sequences 156 
within the same genomic region previously used and classified by Fux et al. (2018) using 157 
Muscle (Edgar, 2004) integrated in MEGA 7 (Kumar et al., 2016). A maximum likelihood 158 
(ML) tree was constructed using the substitution model test with the lowest BIC score 159 
(MEGA7). The Tamura-Nei model was used to build the phylogenetic tree, with 160 
bootstrapping at 1000 replicates to analyse the robustness of the clustering. The tree was 161 
edited using the iTOL program (Letunic and Bork, 2019). Sequences were deposited at 162 
the NCBI GenBank with the accession numbers MK904828 to MK904831. The already 163 
suggested PCV-3 subgrouping classification (PCV-3a1, PCV-3a2, PCV-3b1 and PCV-164 
3b2, Fux et al., 2018) was done regarding the amino acid (aa) motifs from Rep and Cap 165 
proteins. 166 
 167 
2.4 Statistical analysis 168 
The Clopper-Pearson method (Clopper and Pearson, 2006) was used to calculate 169 
the exact confidence interval (CI) at 95% level of confidence for the obtained PCV-3 PCR 170 
positive frequencies. The frequency of PCV-3 DNA detection among the different groups 171 
(R, D and H) and types of lesions within each group was compared with the Chi-square 172 
or Fisher´s exact tests using GraphPad software (GraphPad software Inc., San Diego, 173 
USA). P values <0.05 were considered statistically significant.  174 
 175 
3. RESULTS 176 
3.1 Detection of PCV-3 177 
PCV-3 DNA was found in 19 out of the 315 studied samples (6.0%, 95% 178 
confidence interval, CI: 3.7-9.3). The frequency of detection was 6.2% (8 out of 129, 95% 179 
CI: 2.7-11.9) in pigs from group R and 5.6% (7 out of 126, 95% CI: 2.3-11.1) in pigs 180 
from group D. Viral DNA was also detected to a similar frequency in group H, being 4 181 
out of 60 (6.7%, 95% CI: 1.8-16.2) PCV-3 PCR positive healthy pigs (Table 1). No 182 
statistical differences were observed among studied groups, and no association of any 183 
specific lesion with PCV-3 detection was found. 184 
 Conventional PCR positive samples were quantified by qPCR, except five 185 
samples that were below the quantification limit of the technique (between one and ten 186 
copies of DNA/µL). The PCV-3 load detected in the positive cases was low, with mean 187 
viral loads in the different groups of lesions ranging from 100.5 to 102.8 copies/µL of serum 188 
(Table 1). 189 
 190 
3.2 Sequence and phylogenetic analysis 191 
From the 19 PCR positive samples, 15 sequences from the rep gene fragment were 192 
obtained. From these sequences, eight belonged to pigs from the group R, three from 193 
group D and four from group H. The identity matrix comparing these 15 rep fragments 194 
showed a percentage of identity ranging from 98.34 to 100%. When these fragments were 195 
compared with the same genomic regions of 247 available GenBank reference sequences, 196 
such percentage ranged from 91.99 to 100%.  197 
Four sequences of 1237 nt in length (including the complete rep gene with 890 nt 198 
and part from the cap gene with 347 nt) were obtained from four RCA-PCR positive 199 
samples: two from samples belonging to group H (samples No. 409 and 441); one from 200 
group R (sample No. 1099) and one from group D (sample No. 169). Based on the ML 201 
phylogenetic tree, samples No. 409 and 1099 belonged to the proposed subgroup a1, 202 
while samples No. 441 grouped into subgroup b1  and No. 169 were from subgroup b2 203 
(Figure 1).  204 
 205 
4. DISCUSSION 206 
The present study aimed to expand the current knowledge on PCV-3 respiratory 207 
and digestive disease association based on a case-control study performed with clinical-208 
pathologically well-characterized pigs. Each analysed group corresponded to specific 209 
pathological findings that are generically considered to be caused by bacteria (SBP, P, 210 
FNP, CE, CC) or viruses (IP, AFV+CE) (Caswell and Williams, 2016; Uzal et al., 2016)  211 
In contrast to the two previous studies evaluating such putative relationship (Zhai 212 
et al., 2017; Qi et al., 2019), no significant differences in terms of PCV-3 DNA frequency 213 
detection were found among pigs with respiratory or digestive disorders compared 214 
between them or with age-matched healthy animals. The previously mentioned studies 215 
referred to samples from China and used either serum (Zhai et al., 2017) as in the present 216 
work or intestinal/lung tissues (Qi et al., 2019), collected based exclusively in the animals 217 
showing clinical signs. The matrix (sample type) used for studying PCV-3 frequency of 218 
infection may offer some variability (Phan et al., 2016; Klaumann, Dias-Alves et al., 219 
2018; Shen et al., 2018) and, therefore, may partly explain differing results between the 220 
present study and that of Qi et al. (2019). However, the same potential explanation would 221 
not apply to the other study (Zhai et al., 2017), since serum was also used from affected 222 
and non-affected pigs.  223 
 The two abovementioned works studying the frequency of PCV-3 in pigs with 224 
digestive disorders also included control animals. Specifically, Qi et al. (2019) used 225 
intestinal tissue samples from 480 pigs with acute diarrhoea and/or vomiting and 42 226 
faeces of healthy pigs; whereas 50 out of 480 samples (10.4 %) were PCV-3 PCR positive, 227 
all 42 healthy pigs were found to be negative. On the other hand, Zhai et al. (2017) found 228 
17.14 % (6/35) PCR positive serum samples from pigs with diarrhoea and 2.86 % (1/35) 229 
in animals without clinical signs. Both studies also found significant differences when 230 
comparing pigs affected by respiratory problems and healthy ones. Indeed, Qi et al. 231 
(2019) found 26.6% (25/94) and 0% (0/42) PCV-3 frequencies in diseased and healthy 232 
animals, respectively. Similarly, Zhai et al. (2018) found a PCV-3 PCR positivity of 29% 233 
(split as 63.75%, 51/80, in pigs with severe respiratory disease and 13.14%, 23/175, in 234 
animals with mild signs) and 1.9% (4/216) in healthy pigs, respectively. In another study, 235 
pigs with respiratory disease complex (PRDC) from Thailand showed significantly higher 236 
PCV-3 detection rate (60%, 15/25) in serum compared to healthy pigs (28%, 7/25) 237 
(Kedkovid et al., 2018). The apparently contradictory results offered by the present study 238 
may represent different epidemiological situations in different countries and/or different 239 
sensitivity of PCR techniques used. 240 
Noteworthy, animal selection criteria from previous studies were mainly based on 241 
clinical signs. For this reason, the present work split the clinical conditions by observed 242 
lesions in each case. This selection is important, since lesions like IP and AFV+CE are 243 
generally attributable to viral infections (Caswell and Williams, 2016; Uzal et al., 2016), 244 
but no higher frequency of PCV-3 detection was found in any group of animals displaying 245 
these pathological findings. In consequence, and supported by the fact that very low viral 246 
loads were found in analysed animals, obtained results do not point out to PCV-3 as a 247 
likely cause of these lesions. In contrast, two of the abovementioned Asian studies (Zhai 248 
et al., 2017; Kedkovid et al., 2018) indicated that animals displaying respiratory clinical 249 
signs had higher viral load than healthy ones. In the study from Zhai et al. (2017), pigs 250 
with severe respiratory disease showed Ct values lower than 30 while the ones with either 251 
mild respiratory disease or healthy animals showed Ct values higher than 25 or 30, 252 
respectively (Zhai et al., 2017). The sick pigs from Kedkovid et al. (2018) study presented 253 
titres of 3.2 ± 2.8 log genomic copies/mL, while healthy ones had lower titres (1.6 ± 2.6 254 
log genomic copies/mL). In all cases, it would have been interesting to assess the type of 255 
lesions those diseased animals displayed in these studies. 256 
The relatively low frequency of PCV-3 DNA detection in all pig groups fits 257 
relatively well with a previous retrospective study performed in Spain (Klaumann, Franzo 258 
et al., 2018) where 11.4% (75 out of 654) of PCV-3 serum samples were found PCR 259 
positive. Nevertheless, and based on existing literature, the prevalence of PCV-3 infection 260 
seems to be very variable (Klaumann, Correa-Fiz et al., 2018). This fact makes difficult 261 
to establish if such differences are due to a real variability among countries or simply 262 
reflect the frequency of a limited number or type of samples examined in each study. 263 
The phylogenetic analysis of all obtained partial sequences (the ones with 362 nt 264 
as well as those with 1237 nt) showed high percentage of nucleotide identity compared 265 
to the publicly available sequences, as it has been already published for this virus (Zheng 266 
et al., 2017; Fux et al., 2018; Franzo, Legnardi, Hjulsager et al., 2018; Zhou et al., 2018). 267 
Although Fux et al. (2018) proposed different subtypes for PCV-3, the very high 268 
nucleotide identity of available sequences for this virus do not suggest a potential relation 269 
with the clinical or pathological outcome; in fact, no clustering of the obtained sequences 270 
was observed regarding the disease status.   271 
In summary, PCV-3 DNA was found to similar percentages in pigs affected by 272 
both respiratory and enteric disorders as well as in age-matched healthy animals. 273 
Moreover, no apparent association was found between the presence of viral genome in 274 
serum and particular lesions generally attributed to viral infections in both respiratory and 275 
digestive tracts. Therefore, the results obtained throughout this study do not support a 276 
potential association of PCV-3 with respiratory or enteric disease occurrence. 277 
Definitively, further studies are needed to elucidate the putative association of PCV-3 278 
with different pathological outcomes.  279 
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Figure legend 379 
 380 
FIGURE 1. Phylogenetic analysis of PCV-3 based on partial genome (1237 nt). The 381 
tree was constructed using Maximum likelihood method (Tamura-Nei model) at 1000 382 
bootstrap. Circles in branches represent bootstrap values with sizes proportional to the 383 
bootstrap value (only values higher than 50 are shown). Sequences obtained in the 384 
present study are labelled in red.  Colours indicate the subtypes of PCV-3 suggested by 385 
Fux et al. (2018). 386 
